Virios Therapeutics rises on new U.S. patent for antiviral combination therapy

Dogwood Therapeutics

08/09/2021 15:15

** Shares of biotech co  VIRI.O  rise 7.3% to $6.18
    ** Co says it was granted a new patent for its antiviral
combination therapy (https://refini.tv/3jQFYIm)
    ** United States Patent and Trademark Office has granted
VIRI patent exclusivity on its valacyclovir-celecoxib
combination drug candidate to 2033
    ** VIRI says its intellectual property portfolio now
includes 21 issued patents, consisting of 13 issued U.S. patents
and 8 issued foreign patents, with exclusivity into 2033
    ** Stock has lost ~17.7% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))